OraSure Technologies Inc (OSUR)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $248.57M
Last updated: Nov 17, 2026 at 4:10 PM ET
OraSure Technologies Inc (OSUR) Stock Chart
OraSure Technologies (OSUR) has a latest price of $3.51 on Nov 17, 2026, 23.4% below its 52-week high of $4.58. Its price rose 51.9% over the past 12 months. The month-end price fell 47.5% over the 10 years through Oct 2026, a compound annual decline of 6.2%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $22.50 in Sep 2017 and its lowest $2.38 in Nov 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OSUR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OSUR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 5.1%, and over 6 months it rose 14.0%. The month-end price fell 23.6% over the 3 years through Oct 2026, a compound annual decline of 8.6%.
| Period | Change |
|---|---|
| 1 month | -4.6% |
| 3 months | -5.1% |
| 6 months | +14.0% |
| 12 months | +51.9% |
| 12 months, with dividends | +51.9% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -23.6% | -8.6% |
| 5 years | -63.1% | -18.1% |
| 10 years | -47.5% | -6.2% |
Price by Year
Its best calendar year was 2017, when the price rose 114.8%, and its weakest was 2024, when it fell 56.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.94 | +62.8% |
| 2025 | $2.42 | -33.0% |
| 2024 | $3.61 | -56.0% |
| 2023 | $8.20 | +70.1% |
| 2022 | $4.82 | -44.5% |
| 2021 | $8.69 | -17.9% |
| 2020 | $10.59 | +31.8% |
| 2019 | $8.03 | -31.3% |
| 2018 | $11.68 | -38.1% |
| 2017 | $18.86 | +114.8% |
Trading Range
The price is 5.8% below its 50-day average of $3.73 and 1.4% below its 200-day average of $3.56.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.51 | |
| 52-week high | $4.58 | -23.4% |
| 52-week low | $2.08 | +68.7% |
| 50-day average | $3.73 | -5.8% |
| 200-day average | $3.56 | -1.4% |
Price Risk
Over 3 years, its largest fall from a peak was 74.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.21 |
| Largest fall, 1 year | -28.2% |
| Largest fall, 3 years | -74.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OSUR
What is OSUR's 1-year price change?
OraSure Technologies's price rose 51.9% over the past 12 months. With dividends included, the 12-month total return was 51.9%.
What is OSUR's 5-year price change?
OraSure Technologies's month-end price fell 63.1% over the 5 years through Oct 2026, a compound annual decline of 18.1%. These figures leave out dividends.
What is OSUR's 52-week high and low?
OraSure Technologies's 52-week high is $4.58 and its 52-week low is $2.08. Its latest price of $3.51 on Nov 17, 2026 is 23.4% below the high.
What is OSUR's beta?
OraSure Technologies's 1-year beta against the S&P 500 is 1.21, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 28.2%.
Is the OSUR chart free?
Yes. Advanced Charting for OSUR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OSUR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts